These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 30189860

  • 1. Corticosteroids pulse therapy and oral corticosteroids therapy for IgA nephropathy patients with advanced chronic kidney disease: results of a multicenter, large-scale, long-term observational cohort study.
    Tsunoda R, Usui J, Hoshino J, Fujii T, Suzuki S, Takaichi K, Ubara Y, Yamagata K.
    BMC Nephrol; 2018 Sep 06; 19(1):222. PubMed ID: 30189860
    [Abstract] [Full Text] [Related]

  • 2. Use of corticosteroids in Norwegian patients with immunoglobulin a nephropathy progressing to end-stage kidney disease: a retrospective cohort study.
    Rivedal M, Haaskjold YL, Eikrem Ø, Bjørneklett R, Marti HP, Knoop T.
    BMC Nephrol; 2024 Jan 29; 25(1):42. PubMed ID: 38287343
    [Abstract] [Full Text] [Related]

  • 3. Renal outcome after tonsillectomy plus corticosteroid pulse therapy in patients with immunoglobulin A nephropathy: results of a multicenter cohort study.
    Hoshino J, Fujii T, Usui J, Fujii T, Ohashi K, Takaichi K, Suzuki S, Ubara Y, Yamagata K.
    Clin Exp Nephrol; 2016 Aug 29; 20(4):618-627. PubMed ID: 26577676
    [Abstract] [Full Text] [Related]

  • 4. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec 29; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 5. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.
    Wu H, Fang X, Xia Z, Gao C, Peng Y, Li X, Zhang P, Kuang Q, Wang R, Wang M.
    J Nephrol; 2020 Dec 29; 33(6):1263-1273. PubMed ID: 32507961
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of steroid pulse therapy in combination with mizoribine following tonsillectomy for immunoglobulin A nephropathy in renally impaired patients.
    Kaneko T, Shimizu A, Tsuruoka S, Iino Y, Katayama Y.
    J Nippon Med Sch; 2013 Dec 29; 80(4):279-86. PubMed ID: 23995570
    [Abstract] [Full Text] [Related]

  • 7. Treatment for IgA nephropathy with stage 3 or 4 chronic kidney disease: low-dose corticosteroids combined with oral cyclophosphamide.
    Ma F, Yang X, Zhou M, Bai M, Zhao L, Li L, Dong R, Liu C, Li R, Sun S.
    J Nephrol; 2020 Dec 29; 33(6):1241-1250. PubMed ID: 32447619
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for pregnancy outcomes in patients with IgA nephropathy: a matched cohort study.
    Liu Y, Ma X, Lv J, Shi S, Liu L, Chen Y, Zhang H.
    Am J Kidney Dis; 2014 Nov 29; 64(5):730-6. PubMed ID: 25134778
    [Abstract] [Full Text] [Related]

  • 9. Comparison of administration of single- and triple-course steroid pulse therapy combined with tonsillectomy for immunoglobulin A nephropathy.
    Watanabe-Kusunoki K, Nakazawa D, Yamamoto J, Matsuoka N, Kaneshima N, Nakagaki T, Yamamoto R, Maoka T, Iwasaki S, Tsuji T, Fukasawa Y, Nishimoto N, Nishio S, Atsumi T.
    Medicine (Baltimore); 2021 Dec 17; 100(50):e27778. PubMed ID: 34918629
    [Abstract] [Full Text] [Related]

  • 10. Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy.
    Sato M, Hotta O, Tomioka S, Horigome I, Chiba S, Miyazaki M, Noshiro H, Taguma Y.
    Nephron Clin Pract; 2003 Dec 17; 93(4):c137-45. PubMed ID: 12759582
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
    Chen J, Xu H, Peng Z, Lin L, Li C, Zhu X, Liu S.
    Clin Exp Nephrol; 2020 Jan 17; 24(1):73-81. PubMed ID: 31605314
    [Abstract] [Full Text] [Related]

  • 12. Immunosuppressant Agents as Add-On Therapy Failed to Improve the Outcome of Immunoglobulin A Nephropathy with Crescent Score C1.
    Bi X, Yu Y, Zhou S, Zhou Y, Zhao J, Xiong J.
    Nephron; 2024 Jan 17; 148(9):587-600. PubMed ID: 38723614
    [Abstract] [Full Text] [Related]

  • 13. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
    Xie J, Lv J, Wang W, Li G, Liu Z, Chen H, Xu F, Sun J, Ouyang Y, Zhang X, Yang M, Shi M, Zhang W, Ren H, Kiryluk K, Zhang H, Chen N.
    Am J Kidney Dis; 2018 Sep 17; 72(3):371-380. PubMed ID: 29555434
    [Abstract] [Full Text] [Related]

  • 14. The prognostic effect of immunosuppressive therapy in IgA nephropathy with stage 3 or 4 chronic kidney disease.
    Yang X, Ma F, Bai M, Wang Y, Jia Q, Dong R, Liu C, Sun S.
    Ren Fail; 2021 Aug 10; 43(1):1180-1187. PubMed ID: 34376108
    [Abstract] [Full Text] [Related]

  • 15. Combination therapy of low-dose cyclosporine and steroid in adults with IgA nephropathy
.
    Ihm HS, Lee JY, Hwang HS, Kim YG, Moon JY, Lee SH, Jeong KH, Lee TW, Ihm CG.
    Clin Nephrol; 2019 Sep 10; 92(3):131-140. PubMed ID: 31232271
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of corticosteroid therapy for IgA nephropathy patients stratified by kidney function and proteinuria.
    Nagasawa Y, Yamamoto R, Shinzawa M, Shoji T, Hasuike Y, Nagatoya K, Yamauchi A, Hayashi T, Kuragano T, Moriyama T, Isaka Y.
    Clin Exp Nephrol; 2020 Oct 10; 24(10):927-934. PubMed ID: 32642919
    [Abstract] [Full Text] [Related]

  • 17. Pregnancy and Kidney Outcomes in Patients With IgA Nephropathy: A Cohort Study.
    Su X, Lv J, Liu Y, Wang J, Ma X, Shi S, Liu L, Zhang H.
    Am J Kidney Dis; 2017 Aug 10; 70(2):262-269. PubMed ID: 28320554
    [Abstract] [Full Text] [Related]

  • 18. The improvement of renal survival with steroid pulse therapy in IgA nephropathy.
    Katafuchi R, Ninomiya T, Mizumasa T, Ikeda K, Kumagai H, Nagata M, Hirakata H.
    Nephrol Dial Transplant; 2008 Dec 10; 23(12):3915-20. PubMed ID: 18644797
    [Abstract] [Full Text] [Related]

  • 19. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
    Min L, Wang Q, Cao L, Zhou W, Yuan J, Zhang M, Che X, Mou S, Fang W, Gu L, Zhu M, Wang L, Yu Z, Qian J, Ni Z.
    Oncotarget; 2017 Jul 18; 8(29):48375-48384. PubMed ID: 28415636
    [Abstract] [Full Text] [Related]

  • 20. Low-Dose Corticosteroid Combined With Mycophenolate Mofetil for IgA Nephropathy With Stage 3 or 4 CKD: A Retrospective Cohort Study.
    Zhao J, Ma F, Bai M, Sun S.
    Clin Ther; 2021 May 18; 43(5):859-870. PubMed ID: 33863547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.